XML 19 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 20,611 $ 17,618
Restricted cash, current 0 1,178
Prepaid expenses and other current assets 854 1,897
Total current assets 21,465 20,693
Property and equipment, net 328 483
Operating lease, right-of-use assets 5,019 5,706
Restricted cash, noncurrent 702 696
Other long-term prepaid assets 770 600
Total assets 28,284 28,178
Current liabilities    
Accounts payable 321 1,038
Accrued expenses 5,213 8,415
Deferred research obligation 0 1,169
Operating lease liability, current 981 901
Total current liabilities 6,515 11,523
Warrant liabilities 3,877 2,828
Operating lease liability, noncurrent 4,356 5,105
Long-term debt, net of debt discount and debt issuance costs 9,720 20,034
Total liabilities 24,468 39,490
Commitments and contingencies - Note 9
Stockholders' equity (deficit):    
Common stock, $0.01 par value per share; 300,000,000 shares authorized; 17,273,107 shares and 11,043,837 shares issued at September 30, 2025 and December 31, 2024, respectively; 17,258,652 and 11,029,382 outstanding as of September 30, 2025 and December 31, 2024, respectively 173 110
Treasury stock, at cost, 14,455 shares outstanding (150) (150)
Additional paid-in capital 229,778 183,004
Accumulated other comprehensive loss (31) (175)
Accumulated deficit (225,954) (194,101)
Total stockholders' equity (deficit) 3,816 (11,312)
Total liabilities and stockholders’ equity (deficit) $ 28,284 $ 28,178